Finance

Lists
LINCOLN:NSE
Lincoln Pharmaceuticals Ltd
₹513.00
+1.72%
(+8.65) 1D
Nov 4, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LINCOLN...
Open
₹498.00
High
₹513.90
Low
₹498.00
Mkt. cap
10.28B
Avg. vol.
45.68K
Volume
26.01K
Dividend
0.35%
Quarterly dividend
₹0.45
Ex-dividend date
Sep 11, 2026
P/E ratio
10.65
52-wk high
₹770.00
52-wk low
₹440.00
EPS
₹48.16
Shares outstanding
20.00M
No. of employees
1K
Open
₹498.00
High
₹513.90
Low
₹498.00
Mkt. cap
10.28B
Avg. vol.
45.68K
Volume
26.01K
Dividend
0.35%
Quarterly dividend
₹0.45
Ex-dividend date
Sep 11, 2026
P/E ratio
10.65
52-wk high
₹770.00
52-wk low
₹440.00
EPS
₹48.16
Shares outstanding
20.00M
No. of employees
1K
News stories
From web sources and news partners
Profile
Lincoln Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company is engaged in the manufacturing, marketing and distribution of pharmaceutical products. Lincoln Pharmaceuticals is listed on National Stock Exchange of India and Bombay Stock Exchange. Wikipedia
About Lincoln Pharmaceuticals Ltd
CEO-
Employees1.35K
Founded1979
Headquarters-
SectorPharmaceutical industry
Industry-
Last report
Oct 29, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (INR)
2.01B / -
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.66B
1.87B
1.77B
2.01B
Cost of goods sold
759.60M
967.33M
851.43M
978.97M
Cost of revenue
759.60M
967.33M
851.43M
978.97M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
306.18M
389.12M
333.10M
312.93M
Operating expense
704.87M
684.68M
685.91M
736.46M
Total operating expenses
1.46B
1.65B
1.54B
1.72B
Operating income
198.75M
220.76M
235.48M
293.36M
Other non operating income
151.46M
-379.32M
242.65M
-
EBT including unusual items
347.22M
167.03M
475.54M
290.18M
EBT excluding unusual items
347.22M
146.26M
475.54M
290.18M
Income tax expense
61.22M
50.68M
113.19M
85.92M
Effective tax rate
17.63%
30.34%
23.80%
29.61%
Other operating expenses
361.49M
258.73M
313.96M
384.68M
Net income
286.00M
116.35M
362.34M
204.26M
Net profit margin
17.20%
6.21%
20.44%
10.17%
Earnings per share
-
-
-
-
Interest and investment income
-
82.21M
-
-
Interest expense
-2.98M
-
-2.59M
-3.18M
Net interest expenses
-2.98M
82.21M
-2.59M
-3.18M
Depreciation and amortization charges
37.21M
36.83M
38.84M
38.84M
EBITDA
230.69M
256.62M
271.73M
332.21M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps